Showing 1 - 2 results of 2 for search 'Laura Kooienga', query time: 0.01s Refine Results
  1. 1
    WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (OLE)

    WCN24-752 CONCOMITANT SPARSENTAN AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2is) IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN) IN THE PROTECT OPEN-LABEL EXTENSION (O... by Radko Komers, Laura Kooienga, Robert Malecki, Alex Mercer, Nuhira Ahmed Masthan Ahmed, Priscila Preciado

    Published 2024-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)

    WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) by Jonathan Barratt, Biruh Workeneh, Sung Gyun Kim, Eun Young Lee, Chun Lam, Bess Sorensen, Yuanbo Song, Zeeshan Khawaja, Laura Kooienga

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: